China Vascular Stent Graft Market Size & Growth Rate
According to 6Wresearch internal database and industry insights, the China Vascular Stent Graft Market was valued at USD 1.83 billion in 2025 and is projected to reach USD 2.90 billion by 2032, growing at a CAGR of approximately 6.8% during 2026–2032.
China Vascular Stent Graft Market Highlights
| Report Metric | Details |
| Report Name | China Vascular Stent Graft Market |
| Market Size 2025 | USD 1.83 billion |
| Market Size 2032 | USD 2.90 billion |
| Absolute Growth 2025–2032 | USD 1.07 billion |
| CAGR 2026–2032 | 6.8% |
| Peak Annual Growth | 8.8% in 2028 |
| Forecast Period | 2026–2032 |
| Historical Data | 2022–2025 |
| Base Year | 2025 |
| Leading Stent Type, 2025 | Endovascular Stent Graft (39% share) |
| Leading Material Used, 2025 | Nitinol + PTFE (50% share) |
| Leading Aneurysm Location, 2025 | Abdominal Aneurysm (45% share) |
| Leading End User, 2025 | Surgical Units (50% share) |
| Fastest-Growing Stent Type | Thoracic Stent Graft (7.9% CAGR) |
| Fastest-Growing Material Used | Stainless Steel Frame (8.4% CAGR) |
| Fastest-Growing Aneurysm Location | Thoracic Aorta (8.3% CAGR) |
| Fastest-Growing End User | Cardiac Surgery Centers (8.0% CAGR) |
| Growing Sector | Surgical Units |
| Key End Users | Hospitals, Surgical Units, Cardiac Surgery Centers, Interventional Clinics |
China Vascular Stent Graft Market Year-wise Growth Rate and Key Drivers (2022–2032)
This graph illustrates the annual growth rates of the market from 2022 to 2032, highlighting a steady upward trajectory and projected market expansion over the forecast period.
The following table presents the estimated annual growth rate for each year together with the principal factor influencing market performance.
| Year | Estimated Annual Growth (%) | Market Rationale |
| 2022 | 4.1 | The market experienced steady activity with over 300,000 procedures conducted. |
| 2023 | 7.3 | The demand for vascular stent grafts increased due to rising awareness of minimally invasive options. |
| 2024 | 5.3 | Growth slowed as hospitals adjusted to updated clinical guidelines for aortic aneurysm treatments. |
| 2025 | 8.3 | The market rebounded with strong demand driven by advancements in vascular intervention technology. |
| 2026 | 7.0 | Growth is expected to slow as the market stabilises after a peak in procedure volumes. |
| 2027 | 8.3 | Increased investment in cardiac surgery centres will boost demand for stent grafts. |
| 2028 | 8.8 | The market is projected to peak as the Ministry of Health's program improves access to advanced treatments. |
| 2029 | 4.6 | Growth is expected to slow as the market adjusts to new standards in vascular graft technology. |
| 2030 | 8.6 | Demand will surge again due to rising average life expectancy and related health issues. |
| 2031 | 6.6 | Growth is projected to slow as the market matures and competition intensifies among suppliers. |
| 2032 | 3.8 | The market is expected to grow steadily as healthcare providers adapt to evolving patient needs. |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
China Vascular Stent Graft Market Synopsis
The Vascular Stent Graft Market in China includes medical devices designed to treat aneurysms by providing structural support to blood vessels. These grafts, constructed from materials like nitinol and PTFE, are primarily utilised in hospitals and surgical units. The market benefits from an ageing population and advancements in medical technology. Over 300,000 procedures were reported in 2022, indicating strong demand for these devices. Initiatives from the Ministry of Health further promote market growth, ensuring improved access to vascular treatments for patients nationwide.
Market Dynamics Impact Analysis (2026–2032)
| Factor | Type | Impact | Primary Segment Affected |
| Rising average life expectancy leads to increased vascular health issues. | Driver | High | Endovascular Stent Graft |
| Investment in advanced vascular treatments enhances procedural capabilities. | Driver | High | Thoracic Stent Graft |
| Growing demand for minimally invasive procedures creates opportunities for new entrants. | Opportunity | High | Fenestrated Grafts |
| The need for tailored stent designs for complex anatomies presents market openings. | Opportunity | Medium | Custom-Designed |
| High costs associated with vascular procedures can limit access for some patients. | Restraint | High | Iliac Branch Grafts |
| Regulatory hurdles can delay the introduction of new stent graft products. | Restraint | Medium | Endovascular Stent Graft |
| The Vascular Stent Graft Market in China faces challenges from stringent regulatory requirements. | Challenge | High | Thoracic Stent Graft |
| Competition among suppliers can lead to pricing pressures affecting profitability. | Challenge | Medium | Fenestrated Grafts |
Evaluation of Drivers in China Vascular Stent Graft Market (2026–2032)
Key forces behind demand, with the segment each one moves most, are listed below.
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| Increasing average life expectancy drives demand for vascular interventions. | Endovascular Stent Graft | In 2022, the average life expectancy in China rose, leading to more vascular health issues. |
| Investment in healthcare facilities boosts access to advanced treatments. | Thoracic Stent Graft | Investment in cardiac surgery centers in the Beijing area has increased procedure volumes by 20% over the past two years. |
| Rising awareness of minimally invasive options boosts demand for stent grafts. | Fenestrated Grafts | Interventional clinics reported a growing demand for minimally invasive procedures in recent years, leading to increased purchases. |
| Clinical guidelines for aortic aneurysm treatments are being updated. | Iliac Branch Grafts | Updated guidelines in 2023 influence treatment protocols and increase demand for stent grafts in hospitals. |
| Technological advancements in stent materials improve product offerings. | Nitinol + PTFE | Nitinol stent grafts are preferred for their flexibility and biocompatibility, driving sales. |
Expansion of the Vascular Stent Graft market in China is supported by rising life expectancy, increased investment in healthcare facilities, and heightened awareness of minimally invasive options. In 2022, the average life expectancy in China increased, leading to more vascular health concerns. Investment in cardiac surgery centres in the Beijing area has boosted procedure volumes by 20% over the past two years. The surge in demand for minimally invasive procedures reflects changing patient preferences. Updated clinical guidelines for aortic aneurysm treatments in 2023 are set to further increase demand for stent grafts across various healthcare settings.
Evaluation of Restraints in China Vascular Stent Graft Market
The main factors holding the market back are set out below.
| Market Restraint | Primary Segment Affected | Why It Matters (Evidence) |
| High costs associated with vascular procedures limit patient access. | Iliac Branch Grafts | The average cost of a vascular stent graft procedure in China is around 25,000 CNY, restricting access for many patients. |
| Regulatory hurdles can delay new product introductions. | Endovascular Stent Graft | The Chinese FDA regulates the approval process for new vascular stent graft products, prolonging time to market. |
| Limited awareness in rural areas restricts market growth. | Thoracic Stent Graft | Healthcare providers in rural regions may lack information on advanced treatment options, affecting adoption rates. |
| Intense competition may reduce profit margins for manufacturers. | Fenestrated Grafts | Competition among suppliers can lead to pricing pressures affecting profitability and product availability. |
| Supply chain disruptions can affect product availability. | Nitinol + PTFE | Global supply chain issues have impacted the availability of key materials, delaying production timelines. |
China Vascular Stent Graft Market Challenges
Buyers in the China vascular stent graft market encounter a skills shortage, as training programmes struggle to keep pace with rapid advancements in medical technology. This gap leads to longer procedure times, raising risks for patients in urban hospitals. The average cost of a vascular stent graft procedure is around 25,000 CNY, which limits access for patients, especially in rural clinics. Competition from alternative treatments compels hospitals to lower prices, potentially affecting the quality of care. Regulatory hurdles from the Chinese FDA can delay the approval process for new designs, restricting innovation for healthcare providers.
Trends in the China Vascular Stent Graft Market
Four trends stand out in the China Vascular Stent Graft Market.
- Shift towards Minimally Invasive Procedures: The 2023 National Health Plan promotes minimally invasive procedures, resulting in a notable increase in demand for vascular stent grafts in interventional clinics, with a reported rise in procedures by 15%.
- Emergence of Custom-Designed Grafts: Surgical units are increasingly adopting custom-designed grafts to address complex aortic anatomies, with a notable rise in tailored solutions in recent years, reflecting a shift in treatment approaches.
- Investment in Cardiac Surgery Centers: The Beijing area has experienced increased investment in cardiac surgery centres, with a reported increase in procedure volumes by 20% over the past two years, enhancing service capacity.
- Advancements in Stent Materials: Research funded by the Ministry of Science and Technology focuses on advanced stent materials, with ongoing clinical trials expected to improve product offerings and patient outcomes.
Investment Opportunities in the China Vascular Stent Graft Market
Some of the investment opportunities in the China Vascular Stent Graft Market are mentioned below.
- Rising Demand for Advanced Vascular Treatments: With the average population age increasing, there is a pressing need for advanced vascular treatments, presenting opportunities for new entrants in the market to effectively address this gap.
- Expansion in Cardiac Surgery Centers: Cardiac surgery centres are expanding rapidly, creating a demand for stent grafts tailored to specific patient needs, particularly in urban areas, offering avenues for suppliers.
- Regulatory Approvals for New Products: The Chinese FDA's streamlined approval process for vascular devices opens avenues for manufacturers to introduce new products efficiently, enhancing market competition.
- Growing Need for Custom-Designed Solutions: The demand for custom-designed grafts is increasing, particularly in complex cases, providing manufacturers with a chance to innovate and effectively capture market share.
Government Initiatives in the China Vascular Stent Graft Market
The National Health Commission of China oversees regulations for medical devices, including vascular stent grafts, ensuring compliance with ISO 13485 certification. This certification is essential for manufacturers to demonstrate quality management systems in production. The updated clinical guidelines for aortic aneurysms by the Chinese Society of Cardiology in 2023 also influence treatment protocols, ensuring that patients receive the most effective care available. These measures collectively improve the quality and accessibility of vascular treatments across the country.
In 2023, the Ministry of Health launched a program to improve access to advanced vascular treatments, with a funding allocation of 500 million CNY. The program aims to support healthcare providers in urban and rural areas, ensuring that patients have access to necessary procedures. The China Medical Device Industry Association also plays a role by supporting innovation in vascular graft technology, facilitating research and development initiatives that benefit manufacturers and patients alike.
Future Insight of the China Vascular Stent Graft Market
The China vascular stent graft market is set for substantial change by 2032, driven by an ageing population and a rising preference for minimally invasive procedures. The Ministry of Health's programme to improve access to advanced vascular treatments will broaden patient care options. Clinical trials for new stent designs will introduce advanced materials, supported by funding from the Ministry of Science and Technology, improving treatment efficacy. Updated clinical guidelines from the Chinese Society of Cardiology will ensure best practices among healthcare providers in managing aortic aneurysms.
Market Segmentation Analysis
Each segment group is reviewed below, with the leader by share and the fastest grower by CAGR.
By Stent Type – Endovascular Stent Graft Dominated, Thoracic Stent Graft Expected to Grow Fastest
According to Bhawna Singh, Assistant Manager at 6Wresearch, Endovascular Stent Graft took a 39% share of stent type in 2025, more than any other category. Endovascular stent grafts hold the largest market share due to their widespread use in minimally invasive procedures for treating aneurysms. Their preference among healthcare facilities stems from their ability to significantly reduce recovery times and associated complications, making them a standard choice in many surgical units. The quickest growth will come from Thoracic Stent Graft, forecast to expand at a CAGR of 7.9% between 2026 and 2032. Thoracic stent grafts are experiencing rapid growth, driven by the increasing incidence of thoracic aortic conditions and heightened awareness of effective treatment options. Recent updates in clinical guidelines have further propelled their adoption, ensuring they remain highly relevant in the vascular stent graft market. Suppliers must enhance the availability and features of thoracic stent grafts to effectively address the rising demand.
By Material Used – Nitinol + PTFE Dominated, Stainless Steel Frame Expected to Grow Fastest
In 2025, Nitinol + PTFE led the material used split with a 50% share. Nitinol combined with PTFE holds the largest market share due to its flexibility and durability, making it the preferred choice for vascular stent grafts. This combination is essential for ensuring successful outcomes in various vascular interventions across hospitals. Over 2026–2032, Stainless Steel Frame is expected to post the fastest growth, at a CAGR of 8.4%. The stainless steel frame is gaining traction rapidly, as it offers superior structural integrity for stent designs. This material is increasingly favoured in new product developments, which aligns with the ongoing advancements in vascular technology. Manufacturers must invest in research to improve stainless steel frame designs to capitalise on its growing popularity.
By Aneurysm Location – Abdominal Aneurysm Dominated, Thoracic Aorta Expected to Grow Fastest
With a 45% revenue share in 2025, Abdominal Aneurysm was the largest aneurysm location category. Abdominal aneurysms are the primary focus for vascular grafts, constituting a substantial share of procedures performed in China. This emphasis is primarily due to the high prevalence of abdominal aortic conditions among the ageing population, necessitating effective treatment solutions. Thoracic Aorta is set to record the highest CAGR in this split, 8.3% over 2026–2032. The thoracic aorta segment is experiencing the fastest growth, attributed to rising diagnosis rates of thoracic aortic aneurysms and advancements in treatment protocols. As awareness of thoracic conditions increases, the demand for targeted interventions is expected to surge. Healthcare providers must prepare for an influx of patients requiring thoracic aorta interventions as awareness and diagnosis improve.
By End User – Surgical Units Dominated, Cardiac Surgery Centers Expected to Grow Fastest
The largest end user category in 2025 was Surgical Units, with a 50% share of total revenue. Surgical units command the largest market share as they are the primary setting for stent graft procedures, facilitating a high volume of interventions. Their established infrastructure and expertise play a vital role in delivering effective vascular treatments across the country. Cardiac Surgery Centers are projected to grow fastest, at a CAGR of 8.0% during 2026–2032. Cardiac surgery centers are rapidly expanding, influenced by the increasing number of cardiovascular interventions and significant investments in advanced surgical technologies. This growth aligns with national health initiatives aimed at improving cardiovascular care, positioning these centers for continued success. Suppliers should prioritise partnerships with cardiac surgery centers to leverage the growing demand for advanced vascular interventions.
Key Attractiveness of the Report
- 10 Years of Market Numbers
- Historical Data Starting from 2022 to 2025
- Base Year 2025
- Forecast Data until 2032
- Key Performance Indicators Impacting the Market
- Major Upcoming Developments and Projects
Key Highlights of the Report:
- China Vascular Stent Graft Market Outlook
- Market Size of China Vascular Stent Graft Market, 2025
- Forecast of China Vascular Stent Graft Market, 2032
- Historical Data and Forecast of China Vascular Stent Graft Revenues & Volume for the Period 2022 - 2032F
- China Vascular Stent Graft Market Trend Evolution
- China Vascular Stent Graft Market Drivers and Challenges
- China Vascular Stent Graft Price Trends
- China Vascular Stent Graft Porter's Five Forces
- China Vascular Stent Graft Industry Life Cycle
- Historical Data and Forecast of China Vascular Stent Graft Market Revenues & Volume By Stent Type for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Stent Graft Market Revenues & Volume By Endovascular Stent Graft for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Stent Graft Market Revenues & Volume By Thoracic Stent Graft for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Stent Graft Market Revenues & Volume By Fenestrated Grafts for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Stent Graft Market Revenues & Volume By Iliac Branch Grafts for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Stent Graft Market Revenues & Volume By Material Used for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Stent Graft Market Revenues & Volume By Nitinol + PTFE for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Stent Graft Market Revenues & Volume By Stainless Steel Frame for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Stent Graft Market Revenues & Volume By Custom-Designed for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Stent Graft Market Revenues & Volume By Modular/Segmented for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Stent Graft Market Revenues & Volume By Aneurysm Location for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Stent Graft Market Revenues & Volume By Abdominal Aneurysm for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Stent Graft Market Revenues & Volume By Thoracic Aorta for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Stent Graft Market Revenues & Volume By Complex Aortic Anatomy for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Stent Graft Market Revenues & Volume By Bifurcation Areas for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Stent Graft Market Revenues & Volume By End User for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Stent Graft Market Revenues & Volume By Surgical Units for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Stent Graft Market Revenues & Volume By Cardiac Surgery Centers for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Stent Graft Market Revenues & Volume By Hospitals for the Period 2022 - 2032F
- Historical Data and Forecast of China Vascular Stent Graft Market Revenues & Volume By Interventional Clinics for the Period 2022 - 2032F
- China Vascular Stent Graft Import Export Trade Statistics
- Market Opportunity Assessment By Stent Type
- Market Opportunity Assessment By Material Used
- Market Opportunity Assessment By Aneurysm Location
- Market Opportunity Assessment By End User
- China Vascular Stent Graft Top Companies Market Share
- China Vascular Stent Graft Competitive Benchmarking By Technical and Operational Parameters
- China Vascular Stent Graft Company Profiles
- China Vascular Stent Graft Key Strategic Recommendations
Market Covered
This report examines the market across the segments below.
By Stent Type
- Endovascular Stent Graft
- Thoracic Stent Graft
- Fenestrated Grafts
- Iliac Branch Grafts
By Material Used
- Nitinol + PTFE
- Stainless Steel Frame
- Custom-Designed
- Modular/Segmented
By Aneurysm Location
- Abdominal Aneurysm
- Thoracic Aorta
- Complex Aortic Anatomy
- Bifurcation Areas
By End User
- Surgical Units
- Cardiac Surgery Centers
- Hospitals
- Interventional Clinics
